Trials / Conditions / TP53 Mutation
TP53 Mutation
3 registered clinical trials studyying TP53 Mutation — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer NCT06413992 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Withdrawn | Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer NCT04510584 | University Health Network, Toronto | Phase 2 |
| Unknown | Sintilimab Plus R-CHOP as the First-line Treatment in Patients With Diffuse Large B-Cell Lymphoma. NCT04023916 | Chinese Academy of Medical Sciences | Phase 2 |